Spots Global Cancer Trial Database for Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Official Title: The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia
Study ID: NCT02872818
Study Description
Brief Summary: The purpose of the study is to determine apoptotic signaling pathways such as Survivin, Bcl-2, Bax, c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration.
Detailed Description:
Eligibility
Minimum Age: 8 Weeks
Eligible Ages: CHILD
Sex: FEMALE
Healthy Volunteers: No
Locations
Kayseri Training and Research Hospital, Kayseri, , Turkey
Contact Details
Name: Erdem SAHİN
Affiliation: Kayseri Training and Research Hospital
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
